Elekta divests its stake in ViewRay

STOCKHOLM – Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.

The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million, resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta’s third quarter 2020/21.

# # #

For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail:Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail:cecilia.ketels@elekta.com
Time zone: CET: Central European Time

This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22, 2021. (REGMAR)

About Elekta
近五十年来，Elekta一直是精确放射医学领域的领导者。我们全球4000多名员工致力于确保世界上所有癌症患者都能获得更精确、个性化的放射治疗，并从中受益。总部位于瑞典斯德哥尔摩的Elekta在纳斯达克斯德哥尔摩交易所上市。访问188棋牌捕鱼elekta.comor follow @Elekta on Twitter.

This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22, 2021. (REGMAR)